2014
DOI: 10.1631/jzus.b1400001
|View full text |Cite
|
Sign up to set email alerts
|

Early lethality of shRNA-transgenic pigs due to saturation of microRNA pathways

Abstract: RNA interference (RNAi) is considered as a potential modality for clinical treatment and anti-virus animal breeding. Here, we investigate the feasibility of inhibiting classical swine fever virus (CSFV) replication by short hairpin RNA (shRNA) in vitro and in vivo. We generate four different shRNA-positive clonal cells and two types of shRNA-transgenic pigs. CSFV could be effectively inhibited in shRNA-positive clonal cells and tail tip fibroblasts of shRNA-transgenic pigs. Unexpectedly, an early lethality due… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 18 publications
0
9
0
Order By: Relevance
“…However, small interfering RNAs (siRNAs) target mRNA transcripts and do not target viral DNA in the host cells. Moreover, stable expression of short hairpin RNA (shRNA) is prone to cellular toxicity by overloading the native miRNA pathway with shRNAs [ 15 , 16 ]. The CRISPR/Cas9 system is an adaptive innate immune system that provides resistance to microbes by targeting the nucleic acid of invading bacteriophages in a sequence-specific manner [ 17 ].…”
Section: Introductionmentioning
confidence: 99%
“…However, small interfering RNAs (siRNAs) target mRNA transcripts and do not target viral DNA in the host cells. Moreover, stable expression of short hairpin RNA (shRNA) is prone to cellular toxicity by overloading the native miRNA pathway with shRNAs [ 15 , 16 ]. The CRISPR/Cas9 system is an adaptive innate immune system that provides resistance to microbes by targeting the nucleic acid of invading bacteriophages in a sequence-specific manner [ 17 ].…”
Section: Introductionmentioning
confidence: 99%
“…For example, one of the greatest limitations of using miRNAs as therapeutic targets is the high number of off-targets [47] and undesirable side effects [48] of their introduction, even leading to cell death in drastic cases [49]. It is likely that non-canonical interactions are partially responsible for those effects.…”
Section: Discussionmentioning
confidence: 99%
“…This has also been observed in transgenic pigs expressing anti-classical swine fever virus shRNA (Dai et al 2014). This can be overcome by decreasing the strength of the promoter, incorporating the shRNA into an endogenous miRNA intron or using tissue-specific or transducible promoters (Furth et al 1994;Dickins et al 2007).…”
Section: Technologymentioning
confidence: 99%